Établissement Français du Sang collects, prepares, qualifies and distributes blood transfusion products. The company is headquartered in Saint-Denis, France.

Part of PerkinElmer, Inc. (United States), Kourion Therapeutics is a German company located in Dusseldorf involved in commercial physical and biological research. The firm was acquired by ViaCell, Inc., a subsidiary of PerkinElmer, Inc. (United States) since November 2007, on November 12, 2003.

Maco Pharma designs, manufactures and sells infusion, transfusion and biotherapy systems. The company was founded in 1977 and is headquartered in Tourcoing, France.

New biotechnological company, PraXcell is created in 2003. The company’s principal activity is the development of advanced tools for cellular therapy. These are the human stem cells and the medical devices..\nSince 2004, PraXcell has provided the service to the research team in the isolation of human Stem Cells from cord blood; the Human Umbilical Vein Endothelial Cells (HUVEC) and human Mesenchymal Stem Cells (MSC) from the umbilical cord.\nWith the French source of cord blood, their laboratory can run a reliable and rapid traceability for the quality control of the human stem cell preparation.\nOwner of three patents, PraXcell is developing three medical devices for cellular therapy. These medical instruments include a human cornea kit, a bone marrow harvesting device and a placenta-blood extraction device, which are in the clinical test phase.

SG Meditech Pte Ltd. is a Singaporean private company located in Singapore that manufactures and installs surgical equipment & instruments.

Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France.

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

Operates a biomedical group

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

Tian Qing Stem Cell Co., Ltd. engages in the stem cell extraction and storage services. It is mainly engaged in hematopoietic stem cell storage, umbilical cord mesenchymal stem cell storage, adipose stem cell storage, placental tissue storage and other clinical storage businesses. The company was founded on September 11, 2006 and is headquartered in Harbin, China.

Boya Stem Cell Technology Co. Ltd. develops stem cell technology products. The company is headquartered in Wuxi, China.

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

They are manufacturer of “Disposable ECG Electrodes for medical care” in Japan. There is not much company working on ECG in the world. Therefore, the case example are not much, and they always are challenging to new thing.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.

Yaoding (Beijing) International Cell Medical Technology Co., Ltd., established on 2018-12-19, Business scope includes technology development,Technical Services,technical consulting,technology transfer;Sales of Class I Medical Devices,electronic product,Computer software and auxiliary equipment,Equipment,Packaging Materials,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals);Conference Services;Machinery and Equipment Leasing;property management.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Huilin Biotechnology (Beijing) Co., Ltd., established on 2018-06-28, Business scope includes cell R&D and cell storage technology development,Technical Services,technology transfer,Technology Promotion,technical consulting;Health Advisory,health management(Except for medical treatment activities subject to approval);sell cosmetics,Class II Medical Devices;market survey;Conference Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)